Сочетанная инфекция COVID-19 с ОРИ различной этиологии у детей: распространенность и особенности течения
https://doi.org/10.22627/2072-8107-2023-22-2-43-48
Аннотация
Актуальность проблемы сочетанной инфекции COVID-19 с ОРИ различной этиологии обусловлена высокой распространенностью респираторных инфекций в период эпидемии коронавирусной инфекции. Распространенность сочетанных инфекций COVID-19 с ОРИ по данным литературы варьирует от 0,6 до 45%. Исследования, посвященные особенностям течения сочетанных инфекций COVID-19 с ОРИ различной этиологии у детей, единичны, разнонаправленны и дискуссионны, что требует дальнейшего изучения данной проблемы.
Об авторах
Н. А. Драчева
ФГБОУ ДПО Российская медицинская академия непрерывного профессионального образования (РМАНПО) Минздрава России
Россия
Россия
Драчева Наталья Алексеевна, врач-педиатр, аспирант кафедры детских инфекционных болезней
Москва
Л. Н. Мазанкова
ФГБОУ ДПО Российская медицинская академия непрерывного профессионального образования (РМАНПО) Минздрава России
Россия
Россия
Мазанкова Людмила Николаевна, д.м.н., профессор, зав. кафедрой детских инфекционных болезней педиатрического факультета, гл. внештатный специалист по инфекционным болезням у детей
Москва
Список литературы
1. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 17 (14.12.2022).
2. Yakovlev A. S. еt al. SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children in Moscow in 2020. Int J Infect Dis. 2022 Mar; 116:331—338. doi: 10.1016/j.ijid.2021.12.358.
3. Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020 Sep-Oct; 41(5):102573. doi: 10.1016/j.amjoto.2020.102573.
4. Беляков Н.А., и др. Пандемия COVID-19 и ее влияние на течение других инфекций на Северо-Западе России. ВИЧ-инфекция и иммуносупрессии. 2022; 14(1):7—24. https://doi.org/10.22328/2077-9828-2022-14-1-7-24
5. Киселева И.В., и др. Особенности циркуляции респираторных вирусов в преди пандемические по гриппу и COVID-19 периоды. Инфекция и иммунитет. 2021; 11(6):1009—1019 doi: 10.15789/2220-7619-SFO-166
6. Lansbury L, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; S0163— 4453(20)30323—6. doi:10.1016/j. jinf.2020.05.046
7. Guan Z, et al. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front Public Health. 2021 Dec10; 9:773130. doi:10.3389/fpubh.2021.773130.
8. Swets MC, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022 Apr16; 399(10334):1463—1464. doi: 10.1016/S0140-6736(22)00383-X.
9. Wu HY, et al. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment. J Microbiol Immunol Infect. 2022 Dec; 55(6 Pt 1):985—992. doi: 10.1016/j.jmii.2022.09.006.
10. Rawson T.M., et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020; 71:2459—2468.
11. Baskaran V. , et al. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. J Med Microbiol. 2021 Apr; 70(4):001350. doi: 10.1099/jmm.0.001350
12. Harun Agca, et al. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. Journal of Infection and Public Health. 2021. 14:9:1186—1190. https://doi.org/10.1016/j.jiph.2021.08.004.
13. Hoque MN, et al. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microb Pathog. 2021 Jul; 156:104941. doi:10.1016/j.micpath.2021.104941.
14. Зверева Н.Н., и др. Случаи ко-инфекции COVID-19 и кори у детей. Эпидемиология и Вакцинопрофилактика. 2021; 20(6):81— 87. https://doi.org/10.31631/2073-3046-2021-20-6-81-87
15. Сhih-Cheng Lai, et al. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?, Journal of Microbiology, Immunology and Infection. 2020; 53(4):505—512. https://doi.org/10.1016/j.jmii.2020.05.013.
16. Pooneh Malekifar, et al. Viral Coinfection among COVID-19 Patient Groups: An Update Systematic Review and Meta-Analysis. BioMed Research International, 2021:10. https://doi.org/10.1155/2021/5313832
17. Leuzinger К. et al. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2020 Jul 29: jiaa464. doi: 10.1093/infdis/jiaa46418.
18. Munblit D., et al. Sechenov StopCOVID Research Team. Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clin Infect Dis. 2021 Jul 1; 73(1):1—11. doi: 10.1093/cid/ciaa1535.
19. Порядок ведения детей с острыми респираторными инфекциями, в том числе COVID-19, находящихся на амбулаторном лечении в медицинских организациях государственной системы здравоохранения города Москвы, 2021 г.
20. Hanada S., et al. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol. 2018 Nov 16; 9:2640. doi: 10.3389/fimmu.2018.02640.
21. Зайцева С.В., и др. Микоплазменная инфекция у детей (обзор литературы). РМЖ. 2017; 5:327—334.
22. Waites K.B., et al. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004. 17(4): 697—728.
23. Blasi F., et al. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med. 2005 Dec; 26(6):617—24. doi: 10.1055/s-2005-925525.
24. Kleemola M., et al. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 1988; 157:230.
25. Augenbraun M.H., et al. Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture. Am J Med. 1991; 91:437.
26. Юлиш Е.И., и др. Респираторная инфекция, вызванная Chlamydophila pneumonia, у детей. Подходы к диагностике и лечению. Здоровье ребенка. 2013; 8(51):127—131.
27. Wu Q, et al. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics. 2020 Jul;146(1):e20200961. doi: 10.1542/peds.2020-0961
28. Oliva, A., et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020; 48:871—877. https://doi.org/10.1007/s15010-020-01483-8
29. Gayam V, et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and mycoplasma pneumoniae in the USA. J Med Virol. 2020. https://doi.org/10.1002/jmv.26026.
30. De Francesco M.A., et al. Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J. Infect, 2021; 82:e4—e7.
31. Richardson S., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323:2052—9. https://doi.org/10.1001/jama.2020.6775
32. Mirzaei R., et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020 Oct; 72(10):2097—2111. doi: 10.1002/iub.2356.
33. Amin D., et al. Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients. J Med Virol, 2021; 93:1180—1183.
34. Gayam V., et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J Med Virol, 2020; 92:2181—2187.
35. Hoang A., et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020 Jun 26; 24:100433. doi: 10.1016/j.eclinm.2020.100433.
36. Zhang J-J, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. https://doi.org/10.1111/all.14238
37. Chaudhry R., et al. Atypical bacterial co-infections among patients with COVID-19: A study from India. J Med Virol. 2021; 94:303—309. https://doi.org/10.1002/jmv.27324
38. Kuitunen, I. Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Findings in Children During COVID-19 Pandemic in Finland. SN Compr. Clin. Med. 2022; 4(154). https://doi.org/10.1007/s42399-022-01251-9
39. Plebani A., et al. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children. Clin Immunol. 2020 Dec; 221:108613. doi: 10.1016/j.clim.2020.108613.
40. Ogunbayo AE, et al. Pathogen Profile of Children Hospitalised with Severe Acute Respiratory Infections during COVID-19 Pandemic in the Free State Province, South Africa. Int J Environ Res Public Health. 2022 Aug 21; 19(16):10418. doi: 10.3390/ijerph191610418.
41. Liu, P. et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol. J. 2021; 18(159).
42. Tempia, S., et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Eurosurveillance. 2021; 26:2001600.
43. Han H., et al. Prevalence of Non-SARS-CoV-2 Respiratory Pathogens and Co-Infection with SARS-CoV-2 in the Early Stage of COVID-19 Epidemic. Pathogens. 2022 Nov 4; 11(11):1292. doi: 10.3390/pathogens11111292.
44. Li Y., et al. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children: A retrospective study. Medicine. 2021; 100:e24315.
45. Li B., et al. Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis. Front. Pediatr. 2020; 8:591132.
46. Chan K.-S., et al. Collateral benefits on other respiratory infections during fighting COVID-19. Med. Clínica (Engl. Ed.) 2020; 155:249—253.
47. Adams K., et al. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021—22 Influenza Season. MMWR Morb Mortal Wkly Rep. 2022 Dec 16; 71(50):1589—1596. doi: 10.15585/mmwr.mm7150a4.
48. How To Cite: Mardani M, Nasiri M J. Influenza and COVID-19 Co-infection. Arch Clin Infect Dis.17(3):e131750. doi: 10.5812/archcid-131750.
49. Pata D., et al. Comparison of the Clinical and Laboratory Features of COVID and Influenza in Children. Mediterr JHematol Infect Dis. 2022 Sep 1;14(1):e2022065. doi: 10.4084/MJHID.2022.065.
50. Vink Е., et al. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study. Open Forum Infectious Diseases, 2022; 9(11): ofac531 https://doi.org/10.1093/ofid/ofac531
51. Jiang S, Liu P, Xiong G, Yang Z, Wang M, Li Y, Yu XJ. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children. Clin Chem Lab Med. 2020 Jun 25; 58(7):1160—1161. doi: 10.1515/cclm-2020-0434. PMID: 32301747.
52. Alhumaid S., et al. Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2022 Nov 15; 7(11):380. doi: 10.3390/tropicalmed7110380.
53. Zimmermann P., Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. The Pediatric infectious disease journal. 2020; 39(5):355. doi: 10.1097/INF.0000000000002660
Рецензия
Для цитирования:
Драчева Н.А., Мазанкова Л.Н. Сочетанная инфекция COVID-19 с ОРИ различной этиологии у детей: распространенность и особенности течения. ДЕТСКИЕ ИНФЕКЦИИ. 2023;22(2):43-48. https://doi.org/10.22627/2072-8107-2023-22-2-43-48
For citation:
Dracheva N.A., Mazankova L.N. Сombined infection of COVID-19 with ARI of various etiologies in children: prevalence and features of the course. CHILDREN INFECTIONS. 2023;22(2):43-48. (In Russ.) https://doi.org/10.22627/2072-8107-2023-22-2-43-48
Просмотров: 401
.png)
Послать статью по эл. почте 